PharmX Technologies Limited

ASX:PHX Stock Report

Market Cap: AU$45.5m

PharmX Technologies Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Tom Culver

Chief executive officer

AU$219.3k

Total compensation

CEO salary percentage87.3%
CEO tenure1.2yrs
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenure4.6yrs

Recent management updates

Recent updates

What Is PharmX Technologies Limited's (ASX:PHX) Share Price Doing?

Feb 12
What Is PharmX Technologies Limited's (ASX:PHX) Share Price Doing?

A Look At The Intrinsic Value Of Corum Group Limited (ASX:COO)

Jul 12
A Look At The Intrinsic Value Of Corum Group Limited (ASX:COO)

At AU$0.044, Is Corum Group Limited (ASX:COO) Worth Looking At Closely?

May 11
At AU$0.044, Is Corum Group Limited (ASX:COO) Worth Looking At Closely?

Is Now The Time To Put Corum Group (ASX:COO) On Your Watchlist?

Nov 12
Is Now The Time To Put Corum Group (ASX:COO) On Your Watchlist?

At AU$0.089, Is It Time To Put Corum Group Limited (ASX:COO) On Your Watch List?

Apr 29
At AU$0.089, Is It Time To Put Corum Group Limited (ASX:COO) On Your Watch List?

Corum Group (ASX:COO) Is Posting Healthy Earnings, But It Is Not All Good News

Mar 02
Corum Group (ASX:COO) Is Posting Healthy Earnings, But It Is Not All Good News

Corum Group Limited (ASX:COO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Dec 13
Corum Group Limited (ASX:COO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

CEO Compensation Analysis

How has Tom Culver's remuneration changed compared to PharmX Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$219kAU$191k

AU$95k

Compensation vs Market: Tom's total compensation ($USD137.83K) is below average for companies of similar size in the Australian market ($USD283.48K).

Compensation vs Earnings: Insufficient data to compare Tom's compensation with company performance.

CEO

Tom Culver

1.2yrs

Tenure

AU$219,292

Compensation

Mr. Tom Culver serves as Head of Wealth & Crypto Services at Douugh Limited since January 2021. Mr. Culver is Goodments Founder & CEO. Mr. Culver is Chief Executive Officer of PharmX Technologies Limited f...

Leadership Team

NamePositionTenureCompensationOwnership
Tom Culver
Chief Executive Officer1.2yrsAU$219.29kno data
Zoe Hillier
Chief Financial Officer3.5yrsAU$276.23k0.10%
A$ 47.5k
James Nevile
Chief Operating Officer3.5yrsAU$310.49k0%
A$ 0
Christopher Fernandes
Company Secretaryless than a yearno datano data

2.3yrs

Average Tenure

Experienced Management: PHX's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jayne Shaw
Independent Non-Executive Director4.3yrsAU$97.68k0.46%
A$ 211.4k
Andrew Jonathan Newbery
Non-Executive Director4.9yrsAU$185.37k0.29%
A$ 130.2k
Philip England
Non-Executive Chairman5.2yrsAU$324.28k4.51%
A$ 2.1m
Alexander Mellis
Non-Executive Independent Directorless than a yearno datano data

4.6yrs

Average Tenure

Experienced Board: PHX's board of directors are considered experienced (4.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 01:36
End of Day Share Price 2025/01/06 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PharmX Technologies Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Caleb WengPAC Partners Securities Pty. Ltd.